Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Rissmann

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
British Journal of Clinical Pharmacology|November 23, 2019
Results of phase 2 trials exploring the safety and efficacy of omiganan in patients with human papillomavirus-induced genital lesionsMelanie Rijsbergen, Rianne Rijneveld, Marina Todd, et al.
Clinical Pharmacology and Therapeutics|January 29, 2022
OX40L Inhibition Suppresses KLH-driven Immune Responses in Healthy Volunteers: A Randomized Controlled Trial Demonstrating Proof-of-Pharmacology for KY1005Mahdi Saghari, Pim Gal, Sally Gilbert, et al.
Clinical Pharmacology and Therapeutics|December 22, 2021
Clinical, Cellular, and Molecular Effects of Corticosteroids on the Response to Intradermal Lipopolysaccharide Administration in Healthy VolunteersThomas P Buters, Pieter W Hameeteman, Iris M E Jansen, et al.
Journal of Lower Genital Tract Disease|March 16, 2023
Dermatoscopy and Optical Coherence Tomography in Vulvar High-Grade Squamous Intraepithelial Lesions and Lichen Sclerosus: A Prospective Observational TrialBertine W Huisman, Lisa Pagan, Rosanne G C Naafs, et al.
Experimental Dermatology|November 17, 2023
Lesional skin of seborrheic dermatitis patients is characterized by skin barrier dysfunction and correlating alterations in the stratum corneum ceramide compositionJannik Rousel, Andreea Nădăban, Mahdi Saghari, et al.
Frontiers in Microbiology|December 14, 2023
The vulvar microbiome in lichen sclerosus and high-grade intraepithelial lesionsLisa Pagan, Bertine W Huisman, Michelle van der Wurff, et al.
International Journal of Molecular Sciences|September 28, 2023
Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept TrialJannik Rousel, Mahdi Saghari, Lisa Pagan, et al.
Frontiers in Immunology|June 5, 2026
Early immune responses to intradermal lipopolysaccharide in healthy volunteers: prednisolone's impact on TLR4-mediated inflammationThomas P Buters, Digna T de Bruin, Pieter W Hameeteman, et al.
British Journal of Clinical Pharmacology|June 11, 2026
S. aureus colonization and clinical symptoms remain stable upon topical XZ.700 treatment: Results of a double-blind randomized clinical trial in patients with mild to moderate atopic dermatitisLaura W J van der Meulen, Menthe E Bergmans, Salma Assil, et al.
Frontiers in Immunology|August 7, 2023
Oral prednisolone suppresses skin inflammation in a healthy volunteer imiquimod challenge modelSalma Assil, Thomas P Buters, Pieter W Hameeteman, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
British Journal of Clinical Pharmacology|November 23, 2019
Results of phase 2 trials exploring the safety and efficacy of omiganan in patients with human papillomavirus-induced genital lesionsMelanie Rijsbergen, Rianne Rijneveld, Marina Todd, et al.
Clinical Pharmacology and Therapeutics|January 29, 2022
OX40L Inhibition Suppresses KLH-driven Immune Responses in Healthy Volunteers: A Randomized Controlled Trial Demonstrating Proof-of-Pharmacology for KY1005Mahdi Saghari, Pim Gal, Sally Gilbert, et al.
Clinical Pharmacology and Therapeutics|December 22, 2021
Clinical, Cellular, and Molecular Effects of Corticosteroids on the Response to Intradermal Lipopolysaccharide Administration in Healthy VolunteersThomas P Buters, Pieter W Hameeteman, Iris M E Jansen, et al.
Journal of Lower Genital Tract Disease|March 16, 2023
Dermatoscopy and Optical Coherence Tomography in Vulvar High-Grade Squamous Intraepithelial Lesions and Lichen Sclerosus: A Prospective Observational TrialBertine W Huisman, Lisa Pagan, Rosanne G C Naafs, et al.
Experimental Dermatology|November 17, 2023
Lesional skin of seborrheic dermatitis patients is characterized by skin barrier dysfunction and correlating alterations in the stratum corneum ceramide compositionJannik Rousel, Andreea Nădăban, Mahdi Saghari, et al.
Frontiers in Microbiology|December 14, 2023
The vulvar microbiome in lichen sclerosus and high-grade intraepithelial lesionsLisa Pagan, Bertine W Huisman, Michelle van der Wurff, et al.
International Journal of Molecular Sciences|September 28, 2023
Treatment with the Topical Antimicrobial Peptide Omiganan in Mild-to-Moderate Facial Seborrheic Dermatitis versus Ketoconazole and Placebo: Results of a Randomized Controlled Proof-of-Concept TrialJannik Rousel, Mahdi Saghari, Lisa Pagan, et al.
Frontiers in Immunology|June 5, 2026
Early immune responses to intradermal lipopolysaccharide in healthy volunteers: prednisolone's impact on TLR4-mediated inflammationThomas P Buters, Digna T de Bruin, Pieter W Hameeteman, et al.
British Journal of Clinical Pharmacology|June 11, 2026
S. aureus colonization and clinical symptoms remain stable upon topical XZ.700 treatment: Results of a double-blind randomized clinical trial in patients with mild to moderate atopic dermatitisLaura W J van der Meulen, Menthe E Bergmans, Salma Assil, et al.
Frontiers in Immunology|August 7, 2023
Oral prednisolone suppresses skin inflammation in a healthy volunteer imiquimod challenge modelSalma Assil, Thomas P Buters, Pieter W Hameeteman, et al.
Pageof 10